RIVOLTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 13.672
EU - Europa 6.852
AS - Asia 6.677
SA - Sud America 1.024
AF - Africa 172
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 28.429
Nazione #
US - Stati Uniti d'America 12.943
SG - Singapore 2.332
IT - Italia 1.786
CN - Cina 1.500
DE - Germania 1.193
VN - Vietnam 911
HK - Hong Kong 882
RU - Federazione Russa 830
BR - Brasile 798
CA - Canada 630
SE - Svezia 615
IE - Irlanda 531
GB - Regno Unito 389
UA - Ucraina 359
FR - Francia 248
IN - India 235
FI - Finlandia 229
AT - Austria 157
BD - Bangladesh 127
DK - Danimarca 103
ID - Indonesia 93
TR - Turchia 85
ES - Italia 80
KR - Corea 77
IQ - Iraq 76
AR - Argentina 73
NL - Olanda 71
PL - Polonia 66
ZA - Sudafrica 64
MX - Messico 63
PK - Pakistan 58
JP - Giappone 52
BE - Belgio 51
EC - Ecuador 40
SA - Arabia Saudita 40
PH - Filippine 32
CH - Svizzera 31
CO - Colombia 26
VE - Venezuela 25
CL - Cile 22
UZ - Uzbekistan 22
MA - Marocco 19
PY - Paraguay 19
RO - Romania 19
AE - Emirati Arabi Uniti 17
HU - Ungheria 17
IR - Iran 17
JO - Giordania 16
BG - Bulgaria 15
KE - Kenya 15
EG - Egitto 14
EU - Europa 14
MY - Malesia 14
LT - Lituania 13
AZ - Azerbaigian 11
NP - Nepal 11
AU - Australia 10
DZ - Algeria 10
ET - Etiopia 10
TN - Tunisia 10
AL - Albania 9
PT - Portogallo 8
UY - Uruguay 8
IL - Israele 7
BO - Bolivia 6
BY - Bielorussia 6
CZ - Repubblica Ceca 6
GE - Georgia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
TH - Thailandia 6
CX - Isole del Natale 5
HN - Honduras 5
LB - Libano 5
NG - Nigeria 5
OM - Oman 5
PE - Perù 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KG - Kirghizistan 4
NI - Nicaragua 4
PA - Panama 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
BT - Bhutan 3
GR - Grecia 3
NZ - Nuova Zelanda 3
BJ - Benin 2
KH - Cambogia 2
LY - Libia 2
NO - Norvegia 2
SV - El Salvador 2
TW - Taiwan 2
Totale 28.398
Città #
Ann Arbor 2.122
Singapore 1.439
Ashburn 1.154
Woodbridge 885
Hong Kong 870
Frankfurt am Main 817
Chandler 734
Fairfield 722
San Jose 706
Wilmington 526
Dublin 518
Houston 491
Toronto 441
Milan 424
Dallas 369
Jacksonville 340
New York 331
Santa Clara 313
Dearborn 310
Ho Chi Minh City 271
Seattle 268
Beijing 219
Los Angeles 217
Cambridge 214
Princeton 198
Chicago 186
The Dalles 170
Hanoi 166
Munich 151
Rome 143
Nanjing 142
Vienna 142
Helsinki 124
Shanghai 115
Hefei 111
Lauterbourg 102
Council Bluffs 93
Buffalo 90
Moscow 87
São Paulo 82
Lawrence 80
Altamura 69
Guangzhou 69
Seoul 68
Jakarta 65
Boardman 57
Lachine 54
San Diego 49
Dong Ket 46
London 46
Orem 46
Nanchang 44
Brussels 42
Montreal 42
Fremont 40
Ottawa 39
Denver 37
Andover 35
Haiphong 34
Washington 34
Brooklyn 33
Chennai 33
Tokyo 33
Da Nang 32
Warsaw 32
Johannesburg 31
Changsha 30
Rio de Janeiro 30
Baghdad 29
Bologna 29
Shenyang 29
Tianjin 28
Atlanta 27
Kraków 27
Pune 27
Turku 27
Bari 26
Bergamo 26
Zhengzhou 26
Falls Church 25
Lahore 25
Columbus 24
Nuremberg 24
Phoenix 24
Jinan 23
Philadelphia 23
Poplar 21
Verona 21
Manchester 20
Norwalk 20
Stockholm 20
Tashkent 20
Hebei 19
Mumbai 19
Edmonton 18
Turin 18
Brugherio 17
Dhaka 17
Belo Horizonte 16
Biên Hòa 16
Totale 18.784
Nome #
Vander Fisiologia 686
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 529
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 489
Cardiac and neuronal HCN channelopathies 482
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes 447
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 443
Effect of the ketogenic diet in excitable tissues 434
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 425
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 409
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 406
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 401
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 390
Binary biocompatible CNCs-Gelatine hydrogel as 3D scaffolds suitable for cell culture adhesion and growth 386
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 379
Respiratory Mechanics and Fluid Dynamics After Lung Resection Surgery 374
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 369
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 368
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 363
Brugada syndrome genetics is associated with phenotype severity 355
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 345
Role of the Air-Blood Barrier Phenotype in Lung Oxygen Uptake and Control of Extravascular Water 338
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 335
Hepcidin regulation in a mouse model of acute hypoxia 331
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype 329
Interstitial pressure and lung oedema in chronic hypoxia 328
Cardiopulmonary Consequences of Post Thoracic Surgery Pulmonary Hypertension: Cause or Consequence of Lung Edema? 321
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 320
How ketogenic diet may be beneficial in controlling neuronal excitability? 308
From morphological heterogeneity at alveolar level to the overall mechanical lung behavior: an in vivo microscopic imaging study 308
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 302
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema 298
SCN4A as modifier gene in patients with myotonic dystrophy type 2 298
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020) 298
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes 291
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 289
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 285
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? 284
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 283
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 282
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia 281
Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths 281
Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes 280
Gold Branched Nanoparticles for Cellular Treatments 279
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 278
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death 276
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 276
HCN1 novel mutations in familiar generalized epilepsy 267
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination 264
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 263
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 262
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance 262
Acetylation mediates Cx43 reduction caused by electrical stimulation 261
An outlook on the potential of Si nanocrystals as luminescent probes for bioimaging 259
Identification and functional characterisation of a new KCNJ2 mutation 259
Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 258
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 251
Alveolar mechanics studied by in vivo microscopy imaging through intact pleural space 248
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 244
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene 242
Remodelling of Membrane Rafts Expression in Lung Cells as an Early Sign of Mechanotransduction-Signalling in Pulmonary Edema 242
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes 241
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: “Precision medicine” approach with fluoxetine 240
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons 240
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 239
Computer simulation of wild-type and mutant human cardiac Na+ current 237
T-Type Calcium Channels: A Mixed Blessing 234
Genetics of Long QT, Brugada, and Other Channelopathies 231
Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium 228
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 227
Alterations of the Sialylation Machinery in Brugada Syndrome 225
Invitro- Invivo fluctuation spectroscopies 225
‘In Vitro’, ‘In Vivo’ and ‘In Silico’ Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 223
The effect of exogenous surfactant on alveolar interdependence 218
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 217
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles 217
Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing 217
BS-499656-002 Lethal Autoimmune Channelopathies: Nav1.5 Autoantibodies And Their Role In Sudden Cardiac Death 216
Ion Channel as Target for Drugs 214
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 213
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome 209
Regional Differences in the protein patterns related to lung remodeling and oxygen sensing 209
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 208
Giovanni Alfonso Borelli, Giorgio Baglivi, and the origin of the heartbeat in the seventeenth century 206
Silica encapsulation of luminescent silicon nanoparticles: Stable and biocompatible nanohybrids 198
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 191
Ion channels in the heart 187
Cellular interaction with Si- and Iron-based nanoparticles for bio-imaging. A study of biocompatibility (Conference Paper ) 184
Mechanistic considerations on the development of lung edema: Vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling stage 184
Fisiologia Medica - Terza Edizione 184
Cardiac sodium channel diseases 182
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel 181
Bio-medical and sensor application of silicon nanoparticles 178
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia 176
Vander Fisiologia 174
Comparative expression of two oxygen-dependent transcription factors (O2TF) in lungs, heart and skeletal muscles in a rat model of chronic hypoxia (CH) 169
Markovian model for wild-type and mutant (Y1795C and Y1795H) human cardiac Na/sup +/ channel 166
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes 162
A rabbit model of uremia-induced cardiomyopathy 160
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation 153
Advances in the preparation of novel functionalized nanoparticles for bioimaging 153
Totale 27.957
Categoria #
all - tutte 89.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 0 0 0 0 0 0 0 0 0 256
2021/20221.589 143 180 164 153 72 120 95 78 63 112 123 286
2022/20232.945 321 865 342 302 208 431 24 133 191 25 55 48
2023/20241.833 56 64 84 127 232 473 337 52 137 48 27 196
2024/20254.214 225 424 168 284 385 245 228 202 444 611 315 683
2025/202610.108 1.097 502 928 1.223 1.288 556 1.500 462 910 746 667 229
Totale 29.346